Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00032981 · ClinicalTrials.gov registry record · Phase 3
Motivational Enhancement to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1
A Phase 3 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 3
- Development phase
- 561
- Enrollment target
NCT00032981 is a Phase 3 study that has completed, run by Yale University. The registered enrollment target is 561 participants.
The verdict
NCT00032981, a Phase 3 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 561 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the therapeutic usefulness of incorporating Motivational Enhancement Treatment into the standard drug abuse treatment entry process of Community Treatment Programs on improving treatment engagement, retention, and outcome.
Interventions
- BEHAVIORAL Behavior Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 561 participants |
| Start Date | 2001-05 |
| Est. Completion | 2004-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00032981
The ClinicalTrials.gov registry entry for NCT00032981 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 561 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Behavior Therapy is the first listed.
NCT00032981 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00032981 about?
NCT00032981 is a clinical study titled "Motivational Enhancement to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1". The purpose of this study is to evaluate the therapeutic usefulness of incorporating Motivational Enhancement Treatment into the standard drug abuse treatment entry process of Community Treatment Programs on improving treatment engagement, retention, and outcome.
What is the current status of trial NCT00032981?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 561 participants. The study started on 2001-05. Estimated completion is 2004-08.
What interventions are being tested in trial NCT00032981?
The interventions under investigation include: Behavior Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT00032981?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.